DBV Technologies (DBVT) Treasury Shares (2019 - 2026)
DBV Technologies (DBVT) posted Treasury Shares of $800000.0 for Q2 2026, down 20.0% sequentially from $1.0 million in Q1 2026, and down 35.38% YoY from $1.2 million in Q2 2025.
Analysis
DBV Technologies (DBVT) Treasury Shares (2019 - 2026) Analysis & Trends
DBV Technologies has reported Treasury Shares for 8 years, with the latest figure at $800000.0 in Q2 2026.
- Quarterly Treasury Shares fell 35.38% year-over-year to $800000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $800000.0 (down 35.38% YoY) and the FY2025 annual result came in at $800000.0, down 38.88% from the prior year.
- Treasury Shares fell to $800000.0 in Q2 2026 per DBVT's latest filing, from $1.0 million in the prior quarter.
- Over five years, Treasury Shares peaked at $9.9 million in Q2 2026 and troughed at $74680.0 in Q4 2025.
- A 5-year average of $2.4 million and a median of $2.0 million in 2023 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2022 and 2025: Treasury Shares jumped 75.18% in 2022, then slumped 38.88% in 2025.
- Over 5 years, Treasury Shares stood at $1.1 million in 2022, then rose by 13.89% to $1.3 million in 2023, then climbed by 3.64% to $1.3 million in 2024, then slumped by 38.88% to $800000.0 in 2025, then changed by 0.0% to $800000.0 in 2026.
- According to Business Quant data, Treasury Shares over the past three periods registered $800000.0, $1.0 million, and $800000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | DBV Technologies | 5.88 Bn | 5.70 Bn | - | 146,321.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 800,000.00 |
| Jun 30, 2026 | 146,321.00 |
| Jun 30, 2026 | 146,321.00 |
| Jun 30, 2026 | 800,000.00 |
| Mar 31, 2026 | 128,068.00 |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 128,068.00 |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 74,680.00 |
| Dec 31, 2025 | 74,680.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 1.12 Mn |
| Sep 30, 2025 | 159,651.00 |
| Sep 30, 2025 | 159,651.00 |
| Sep 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 210,169.00 |
| Jun 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 210,169.00 |
| Jun 30, 2025 | 1.24 Mn |